FDA Plays

[YoungGateSaysGreen]

SPEXD, Reverse Split has been done and only 3mill shares with less then 2mil float. Trial 3 has been completed. Load up now, what to expect soon is a NDA

NDA will come anytime


Spherix will prepare a New Drug Application (NDA) for presentation to the Food and Drug Administration (FDA). FDA approval would give Spherix the right to market Naturlose® as a diabetes drug. Naturlose® has already been shown to be safe. Our facilities include laboratory and research areas specially designed to meet the specific areas of emphasis of our research partners and customers with a focus toward improving technologies for health and the environment

-Im green cause i play 3steps ahead of the market